Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Krishnan promoted to president and head of R&D at OncoNano

Plus: McCourt becomes co-CEO of Hudson, and updates from MeMed, Enhance3D and Avalyn

November 7, 2023 1:40 AM UTC

OncoNano Medicine Inc. promoted Kartik Krishnan to the new role of president and head of R&D from CMO. Before joining OncoMed in 2022, Krishnan was CMO at Arcus Biosciences Inc. (NYSE:RCUS). OncoNano is developing a pH-sensitive polymeric micelle technology to diagnose and treat solid tumors.

Inflammatory and immuno-oncology company Hudson Therapeutics Inc. named Janice McCourt as co-CEO and a board member. In her role as co-CEO, McCourt will be responsible for the business development division, with a focus on research collaborations and licensing deals.  She was CBO at Comera Life Sciences Holdings Inc. (NASDAQ:CMRA)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article